Accupril and Tyvaso drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Accupril (quinapril hydrochloride) and Tyvaso (treprostinil sodium). Common drug interactions include constipation among females and myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Accupril and Tyvaso. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Accupril?

Accupril has active ingredients of quinapril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 13,404 Accupril users. Check the latest studies of Accupril.

What is Tyvaso?

Tyvaso has active ingredients of treprostinil sodium. eHealthMe is studying from 37,941 Tyvaso users. Check the latest studies of Tyvaso.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

15 people who take Accupril and Tyvaso together, and have interactions are studied.

What are the common drug interactions of Accupril and Tyvaso, by gender? *:

female:

Constipation
Dyspnoea (difficult or laboured respiration)
Hypersensitivity
Swelling

male:

Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Dyspnoea (difficult or laboured respiration)
Malaise (a feeling of general discomfort or uneasiness)
Nasal septum perforation (hole in nasal septum)
Peripheral swelling
Pruritus (severe itching of the skin)
Rash
Anaemia (lack of blood)
Chest discomfort
Epistaxis (bleed from the nose)

What are the common drug interactions of Accupril and Tyvaso, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Dyspnoea (difficult or laboured respiration)
Limb injury
Lung cancer metastatic (lung cancer spreads to other parts)
Malaise (a feeling of general discomfort or uneasiness)
Nasal septum perforation (hole in nasal septum)
Peripheral swelling
Pruritus (severe itching of the skin)
Rash
Swelling

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 66.67%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Accupril and Tyvaso?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously